Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder
Open Access
- 30 July 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (15) , 9346
Abstract
Opioid-related fatalities increased exponentially during the COVID-19 pandemic and show little sign of abating. Despite decades of scientific evidence that sustained engagement with medications for opioid use disorders (MOUD) yields positive psychosocial outcomes, less than 30% of people with OUD engage in MOUD. Treatment rates are lowest for women. The aim of this project was to identify women-specific barriers and facilitators to treatment engagement, drawing from the lived experience of women in treatment. Data are provided from a parent study that used a community-partnered participatory research approach to adapt an evidence-based digital storytelling intervention for supporting continued MOUD treatment engagement. The parent study collected qualitative data between August and December 2018 from 20 women in Western Massachusetts who had received MOUD for at least 90 days. Using constructivist grounded theory, we identified major themes and selected illustrative quotations. Key barriers identified in this project include: (1) MOUD-specific discrimination encountered via social media, and in workplace and treatment/recovery settings; and (2) fear, perceptions, and experiences with MOUD, including mental health medication synergies, internalization of MOUD-related stigma, expectations of treatment duration, and opioid-specific mistrust of providers. Women identified two key facilitators to MOUD engagement: (1) feeling “safe” within treatment settings and (2) online communities as a source of positive reinforcement. We conclude with women-specific recommendations for research and interventions to improve MOUD engagement and provide human-centered care for this historically marginalized population.Keywords
Funding Information
- University of Massachusetts Worcester Center for Clinical and Translational Science (UMCCTS) (UL1TR001453, UG3 DA0044830-02S1, 1H79T1081387-01)
- Greenwall Foundation, the National Institute on Drug Abuse (NIDA) (UL1TR001453, UG3 DA0044830-02S1, 1H79T1081387-01)
- Substance Abuse and Mental Health Services Administration (SAMHSA) (UL1TR001453, UG3 DA0044830-02S1, 1H79T1081387-01)
This publication has 73 references indexed in Scilit:
- Utilizing Peer Mentorship to Engage High Recidivism Substance-Abusing Patients in TreatmentThe American Journal of Drug and Alcohol Abuse, 2011
- Age and Gender Trends in Long-Term Opioid Analgesic Use for Noncancer PainAmerican Journal of Public Health, 2010
- Substance abuse treatment entry, retention, and outcome in women: A review of the literatureDrug and Alcohol Dependence, 2007
- Five Misunderstandings About Case-Study ResearchQualitative Inquiry, 2006
- Defining Cultural Competence: A Practical Framework for Addressing Racial/Ethnic Disparities in Health and Health CarePublic Health Reports®, 2003
- Effectiveness Of Substance Abuse Treatment Programming For Women: A ReviewThe American Journal of Drug and Alcohol Abuse, 2003
- High sugar intake in a group of women on methadone maintenance in South Western Sydney, AustraliaAddiction, 1996
- Ambivalence Toward Methadone Treatment Among Intravenous Drug UsersJournal of Psychoactive Drugs, 1991
- Grounded theory research: Procedures, canons, and evaluative criteriaQualitative Sociology, 1990
- Addict Attitudes toward Methadone Maintenance: A Preliminary ReportInternational Journal of the Addictions, 1974